TY - JOUR
T1 - EUSOMA quality indicators for non-metastatic breast cancer
T2 - An update
AU - Rubio, Isabel T
AU - Marotti, Lorenza
AU - Biganzoli, Laura
AU - Aristei, Cynthia
AU - Athanasiou, Alexandra
AU - Campbell, Christine
AU - Cardoso, Fatima
AU - Cardoso, Maria Joao
AU - Coles, Charlotte E
AU - Eicher, Manuela
AU - Harbeck, Nadia
AU - Karakatsanis, Andreas
AU - Offersen, Birgitte V
AU - Pijnappel, Ruud
AU - Ponti, Antonio
AU - Regitnig, Peter
AU - Santini, Donatella
AU - Sardanelli, Francesco
AU - Spanic, Tanja
AU - Varga, Zsuzsanna
AU - Vrancken Peeters, Marie Jeanne T F D
AU - Wengström, Yvonne
AU - Wyld, Lynda
AU - Curigliano, Giuseppe
N1 - Publisher Copyright:
© 2024
PY - 2024/2
Y1 - 2024/2
N2 - INTRODUCTION: Quality care in breast cancer is higher if patients are treated in a Breast Center with a dedicated and specialized multidisciplinary team. Quality control is an essential activity to ensure quality care, which has to be based on the monitoring of specific quality indicators. Eusoma has proceeded with the up-dating of the 2017 Quality indicators for non-metastatic breast cancer based on the new diagnostic, locoregional and systemic treatment modalities.METHODS: To proceed with the updating, EUSOMA setup a multidisciplinary working group of BC experts and patients' representatives. It is a comprehensive set of QIs for early breast cancer care, which are classified as mandatory, recommended, or observational. For the first time patient reported outcomes (PROMs) have been included. As used in the 2017 EUSOMA QIs, evidence levels were based on the short version of the US Agency for Healthcare Research and Quality.RESULTS: This is a set of quality indicators representative for the different steps of the patient pathway in non-metastatic setting, which allow Breast Centres to monitor their performance with referring standards, i.e minimum standard and target.CONCLUSIONS: Monitoring these Quality Indicators, within the Eusoma datacentre will allow to have a state of the art picture at European Breast Centres level and the development of challenging research projects.
AB - INTRODUCTION: Quality care in breast cancer is higher if patients are treated in a Breast Center with a dedicated and specialized multidisciplinary team. Quality control is an essential activity to ensure quality care, which has to be based on the monitoring of specific quality indicators. Eusoma has proceeded with the up-dating of the 2017 Quality indicators for non-metastatic breast cancer based on the new diagnostic, locoregional and systemic treatment modalities.METHODS: To proceed with the updating, EUSOMA setup a multidisciplinary working group of BC experts and patients' representatives. It is a comprehensive set of QIs for early breast cancer care, which are classified as mandatory, recommended, or observational. For the first time patient reported outcomes (PROMs) have been included. As used in the 2017 EUSOMA QIs, evidence levels were based on the short version of the US Agency for Healthcare Research and Quality.RESULTS: This is a set of quality indicators representative for the different steps of the patient pathway in non-metastatic setting, which allow Breast Centres to monitor their performance with referring standards, i.e minimum standard and target.CONCLUSIONS: Monitoring these Quality Indicators, within the Eusoma datacentre will allow to have a state of the art picture at European Breast Centres level and the development of challenging research projects.
KW - Breast cancer care
KW - Quality control
KW - Quality indicators
UR - http://www.scopus.com/inward/record.url?scp=85181829424&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2023.113500
DO - 10.1016/j.ejca.2023.113500
M3 - Article
C2 - 38199146
SN - 0959-8049
VL - 198
JO - European Journal of Cancer
JF - European Journal of Cancer
M1 - 113500
ER -